Original research
par
Bharat, Chrianna et al
Date de publication
2021
Géographie
Australia
Langue de la ressource
English
Texte disponible en version intégrale
Non
Open Access / OK to Reproduce
Non
Évalué par des pairs
Yes
L’objectif
This study estimated retention in buprenorphine and methadone treatment and its relationship with person, treatment and prescriber characteristics.
Constatations/points à retenir
In New South Wales, Australia, retention in buprenorphine treatment for opioid dependence, compared with methadone, has improved over time since its introduction in 2001. Opioid agonist treatment retention is affected not only by characteristics of the person and his or her treatment, but also of the prescriber, with those of longer prescribing tenure associated with increased retention of people in opioid agonist treatment.
La conception ou méthodologie de recherche
Retrospective cohort study
Mots clés
About prescribers
Substitution/OAT
